UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2)
Young & Rubicam Inc.
- -----------------------------------------------------------------
(Name of Issuer)
Common Stock
- -----------------------------------------------------------------
(Title of Class of Securities)
987425105
-------------------------------------------
(CUSIP Number)
Mark T. McEnroe, c/o Young & Rubicam Inc.,
285 Madison Avenue, New York, New York 10017, 212-210-3427
- -----------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
December 1, 1998
-------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is the subject of this
Schedule 13D, and is filing this schedule because of Sections
240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following
box. [ ]
Note: Schedules filed in paper format shall include a signed
original and five copies of the schedule, including all exhibits.
See Section 240.13d-7(b) for other parties to whom copies are to
be sent.
*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in
a prior cover page.
The information required on the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
SCHEDULE 13D
- ----------------------- -----------------------
CUSIP No. 987425105 Page 2
- ----------------------- -----------------------
- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Michael J. Dolan
- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
- ---------------------------------------------------------------------
3 SEC USE ONLY
- ---------------------------------------------------------------------
4 SOURCE OF FUNDS
00
- ---------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- ---------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- ---------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER 0
OF -----------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY
OWNED 0
BY -----------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 419,625
WITH -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
- ---------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
419,625
- ---------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- ---------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
*
- ---------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- ---------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
- ----------------------- -----------------------
CUSIP No. 987423105 Page 3
- ----------------------- -----------------------
- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Stephanie W. Abramson
- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
- ---------------------------------------------------------------------
3 SEC USE ONLY
- ---------------------------------------------------------------------
4 SOURCE OF FUNDS
00
- ---------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- ---------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- ---------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER 0
OF -----------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY
OWNED 0
BY -----------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 466,978
WITH -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
- ---------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
466,978
- ---------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- ---------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
*
- ---------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- ---------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
- ----------------------- -----------------------
CUSIP No. 987425105 Page 4
- ----------------------- -----------------------
- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Kevin Lavan
- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [X]
- ---------------------------------------------------------------------
3 SEC USE ONLY
- ---------------------------------------------------------------------
4 SOURCE OF FUNDS
00
- ---------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- ---------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- ---------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER 0
OF -----------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY
OWNED 0
BY -----------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 62,250
WITH -----------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
- ---------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
62,250
- ---------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- ---------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
*
- ---------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- ---------------------------------------------------------------------
<PAGE>
This Amendment No. 2 (this "Amendment") amends and
supplements the Schedule 13D filed on November 13, 1998 (the
"Original Schedule 13D"), as amended by Amendment No. 1 filed on
November 25, 1998, by Michael J. Dolan, Stephanie W. Abramson and
Kevin Lavan with respect to the common stock, $0.01 par value per
share ("Common Stock"), of Young & Rubicam Inc., a Delaware
corporation (the "Company"). All capitalized terms used in this
Amendment and not otherwise defined herein have the meanings
ascribed to such terms in the Schedule 13D.
Item 4. Purpose of Transaction.
Item 4 of the Original Schedule 13D is hereby amended by
inserting the following paragraphs immediately prior to the final
paragraph thereof.
On December 1, 1998, the Y&R Selling Shareholders listed on
Schedule 1 hereto, together with certain other stockholders of
the Company, closed the sale of Common Stock pursuant to the
Underwriting Agreement. Pursuant to the Underwriting Agreement,
the Y&R Selling Stockholders sold to the Underwriters, acting
through the Representatives, 5,180,647 shares of Common Stock
(including 1,047,166 shares of Common Stock issued upon exercise
of options held by the Y&R Selling Stockholders) for resale
pursuant to the Company's Registration Statement on Form S-1 and
the Final Prospectus, at a price of $29.50 per share, less an
underwriting discount of $1.18 per share, resulting in net
proceeds to the Y&R Selling Stockholders of $28.32 per share of
Common Stock. In addition, other stockholders of the Company
named in the Underwriting Agreement and the Final Prospectus sold
4,819,353 shares of Common Stock to the Underwriters, acting
through the Representatives on the same terms.
Item 5. Interest in Securities of the Issuer.
Item 5 of the Original Schedule 13D is hereby amended to
read in its entirety as follows:
(a) At the date hereof, Michael J. Dolan beneficially owns
419,625 shares of Common Stock, constituting less than 1%
of the shares outstanding. At the date hereof, Stephanie W.
Abramson beneficially owns 466,978 shares of Common Stock,
constituting less than 1% of the shares outstanding. At the
date hereof, Kevin Lavan beneficially owns 42,250 shares of
Common Stock, constituting less than 1% of the shares
outstanding. The number of shares of Common Stock beneficially
owned by each Reporting Person and the percentage of outstanding
shares represented thereby have been computed in accordance with
Rule 13d-3 under the Exchange Act.
(b) At the date hereof, Michael J. Dolan has the sole power
to dispose of 419,625 shares of Common Stock, which includes
104,340 shares of Common Stock which are issuable pursuant to
curently exercisable options, held in an individual capacity;
Stephanie W. Abramson has the sole power to dispose of 466,978
shares of Common Stock, which includes 26,085 shares of Common
Stock which are issuable pursuant to currently exercisable
options, held in an individual capacity; and Kevin Lavan has the
sole power to dispose of 62,250 outstanding shares of Common
Stock held in an individual capacity, which includes 12,000
shares of Common Stock that are issuable pursuant to currently
exercisable Options.
(c) Except as described herein, the Reporting Persons have
effected no transactions in shares of Common Stock during the
past 60 days.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in
this statement is true, complete and correct.
Dated: December 2, 1998
By: /s/ Mark T. McEnroe,
Attorney-in-Fact, on behalf
of Michael J. Dolan
--------------------------
Name: Mark T. McEnroe
Title: Attorney-in-Fact
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in
this statement is true, complete and correct.
Dated: December 2, 1998
By: /s/ Mark T. McEnroe,
Attorney-in-Fact, on behalf
of Stephanie W. Abramson
--------------------------
Name: Mark T. McEnroe
Title: Attorney-in-Fact
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in
this statement is true, complete and correct.
Dated: December 2, 1998
By: /s/ Mark T. McEnroe,
Attorney-in-Fact, on behalf
of Kevin Lavan
--------------------------
Name: Mark T. McEnroe
Title: Attorney-in-Fact
<PAGE>
Schedule 1
Y&R Selling Stockholders
as of December 1, 1998
Maximum Number of
Shares of Common Stock
(including shares of
Common Stock issuable
upon the exercise of
Name of Y&R Selling Stockholder options)
- ------------------------------- ----------------------
AIELLO, STEPHEN R. 20,105
ALBINUS, STIG 16,140
ANASTOS, PATRICIA 2,000
BARA, JEAN-MARC 35,588
BAUM, STEPHEN 2,000
BEALLE, KIMBERLY 10,000
BEIJEN, KAREL 3,510
BELL, THEODORE 40,000
BERGERUS-HOBINGER, LEENA 45,570
BJORKMAN, LINCOLN 15,615
BLOCKLIN, JUNE 29,520
BOENDER, RENE 12,078
BOHNE, BONNIE 2,430
BOISROND, ETIENNE 33,750
BOSMA, TIEMEN 55,000
BRANDS, HEINZ GEORG 9,733
BRANIGAN, CRAIG 28,000
BRAUN, JURGEN 71,970
BRITE, JANE 40,000
CHIOCCI, ROGER 14,000
CHYNSKY, IRA 16,000
CLAES, MICHAEL 5,000
COGMAN, DON 61,600
COOMBS, JANET 19,327
CORONNA, DAVID 700
COSTA, JOSE MARIA 15,000
COSTA, MASSIMO 7,406
COZENS, MICHAEL 5,220
CURRAN, BRIAN 15,651
DAVIS, DONALD H. 19,080
De BAKKER, FERDINAND 15,000
DEDEO, JOSEPH E. 201,258
DEUTSCH, LAWRENCE 1,400
DIAMOND, SHELLEY 10,875
DuBOSE, PAMELA 20,000
DUKES, TERRY 6,250
ELLIOTT, DARYL 5,200
EXPOSITO, DAISY 31,709
FAHEY, KEVIN J. 4,500
FARLEY, CHARLES P. 5,000
FARNELL-WATSON, PETER 20,355
FORD, PATRICK 9,000
FORD, RICHARD 18,000
FRANKEL, CLARK J. 26,088
FRANZ, VOLKER 1,000
FREDERICKS, ERIC 39,000
FREDERIKSEN, PETER 9,000
GAZMA, LEON 10,000
GERVASI, ENRICO 9,000
GOMEZESE, OSCAR 2,000
GONZALES, EDUARDO 40,000
GREEN, WILLIAM 10,000
GREENE, DAVID E. 10,000
GUTIERREZ, VICTOR 6,000
HALLEY-WRIGHT, ANDREW 37,125
HANSEN, THOMAS R. 750
HARLEMAN, PETER J. 16,000
HAWRYSH, FRED 17,400
HIMPE, STEFAAN 5,000
HOOD, JAMES W. 35,000
HORN, ROSEANNE 10,350
HOROVITZ, PETER 6,957
HOSP, RICHARD H. 20,000
HOYT, ERIC GARRISON 11,900
<PAGE>
HUGHES, ALEX 34,785
HUNT, JEFF 15,279
IBBA, GIGLIOLA 15,000
IGIEL, ROBERT 52,175
JACK, BARBARA 89,370
JEBSEN, PAL MARIUS 28,000
JOHNSTON, WILLIAM B. 6,000
KAPLOVE, JAMES E. 8,000
KENNY, MARY ELLEN 6,522
KISSMANN, EDNA 13,000
KLEIN, ARTHUR R. 30,000
KOH, JACKIE 15,500
KOWALEWSKA, NINA 12,000
KRAKOWSKY, PHILIPPE 6,000
KRAUSS, INGO 150,000
KUGELMAN, STEPHANIE 72,794
KURZ, MITCHELL 356,000
KUSHNER, JAY 11,000
La ROCK, MARTA 10,000
LAING, TIMOTHY 4,135
LEO, DENISE 675
LOES, RENATO ARANTES 39,135
LOMBARDI, MARCO 20,000
MACHTIGER, BENNETT R. 7,000
MACKINNON, DUNCAN 5,000
MALTESE, JOHN F. 16,983
MANSON, ANTHONY S. 16,305
MATTHIES, HELMUT 125,000
MAURICE, MARTIN 15,000
McDUFFEY, ROBERT M. 12,000
McGARRY, JOHN 309,706
McKENNA, STEVEN M. 92,000
McLEAN, GORDON 11,955
McQUEENEY, THOMAS 34,765
MEERSTADT, BERT 8,000
MELZER, WILLIAM C. 73,300
MESKILL-SPENCER, DIANE 22,767
MIDDLETON, CRAIG 31,467
MINEAR, DAVID 12,000
MONTERO, FERNAN 282,000
MOOTZ, FRANS 18,792
MORRIS, JOHN F. 12,432
NELSON, BRUCE S. 6,500
NEWTON, JR., CHARLES G. 7,560
NEWTON, KEITH 26,250
NICHOLSON, LORI 11,379
O'MALLEY, JAMES 13,560
OROHO, STEVE 64,988
O'ROURKE, RAYMOND J. 10,000
OWEN, STEWART 20,000
PARRY, VINCENT P. 10,000
PASTRICK, ROBERT S. 17,220
PEREZ, MANUEL 32,000
PEREZ, RICARDO J. 49,575
PERLMUTTER, DIANE 7,500
PETERS, JOHN 28,710
PHILLIPS, GRAHAM 4,960
POLLAK, TIM 264,000
PORTER, MICHAEL 15,610
POWER, WILLIAM A. 50,000
PRATT, TOM 10,000
PROCTER, BRIAN 6,450
PUPHAL, JOERG 32,000
PUTNAM, JOHN E. 9,173
QUADFLIEG, MATTHIAS 5,475
<PAGE>
RANCOURT, SERGE 40,000
RAVIV, SHEILA 15,000
REESER, COURTNEY 12,522
RENTSCHLER, PETER 6,087
RINDLISBACHER, JORG 8,000
RODRIGUEZ, JORGE 1,755
RODWAY, EDWARD 6,450
ROSENTHAL, ILENE 10,000
ROSS, JOHN J. 5,000
ROTHSTEIN, SEITH 33,915
ROUSSET, ALAIN 55,352
SAMET, MICHAEL 38,568
SANDERS, JOHN 20,000
SAVAGE, CHRIS 13,050
SCHETLICK, MATTHEW 7,000
SCHOU, NICO 13,755
SCHUG, ANGELIKA 20,000
SCIELZO, JAMES 23,733
SCRUGGS, JOHN F. 26,085
SEYFERTH, STEVE 10,000
SHARP, KEITH 17,742
SHAW, JESSIE 3,500
SHELDON, ALAN J. 250,000
SINREICH, RICHARD 11,000
SIVE, ROBERT 12,590
SLONE, PETER B. 10,650
SMITH, TIMOTHY H. 6,000
SRERE, LINDA 15,000
STADELER, CHRISTOPH 23,000
STEFANSKI, STANLEY 80,321
STEIGRAD, PETER 1,000
STERN MARRONE, DEBRA 8,000
STOUT, KATHRYN 7,000
THALEN, LARS 14,000
TIMON, CLAY 36,511
TRAUB, WAYNE 5,500
VIJN, PIETER 10,000
WALDMAN, MARVIN 24,100
WALSH, MARY T. 2,000
WEBRE, CHARLES 13,914
WIDMER, BRUNO 65,000
WILLIAMS, DONALD D. 18,000
WILLIAMS, JAMES 22,500
YAGODA, KENNETH 6,000
ZEIGLER, MICHAEL 23,185
Total 5,180,647
<PAGE>
EXHIBIT INDEX
Exhibit 1 Underwriting Agreement (incorporated by reference
to Amendment No. 1 to the Original Schedule 13D
filed with the Securities and Exchange Commission
on November 25, 1998)
Exhibit 2 Joint Filing Agreement (incorporated by reference
by reference to the Original Schedule 13D filed
with the Securities and Exchange Commission on
November 13, 1998)
